Medicaid, Vaccines & NIH Nutrition News
- More then 70 nutrition scientists have signed a public letter to National Institutes of Health (NIH) Director Jay Bhattacharya, alleging censorship within the agency.The scientists are demanding that...
- The letter follows allegations from former NIH nutrition scientist Kevin Hall, who claimed his research on ultra-processed foods was curtailed due to interference from superiors.
- Meanwhile, the Trump administration is urging pharmaceutical companies to voluntarily lower drug prices and allow direct sales to American consumers.
Nutrition scientists are raising alarms about alleged censorship at the NIH, a critical development impacting health research. Together, the trump administration is ramping up pressure on pharmaceutical companies to slash drug prices, creating waves in the healthcare sector. This article from News Directory 3 unpacks these key policy shifts, including the potential impact of proposed Medicaid work requirements on coverage. The analysis also considers the potential risks tied to Robert F. Kennedy Jr.’s vaccine committee approach. Stay informed on the latest developments—discover what’s next.
NIH Faces Censorship Claims as Trump Pushes for Lower Drug Prices
Updated June 15, 2025
More then 70 nutrition scientists have signed a public letter to National Institutes of Health (NIH) Director Jay Bhattacharya, alleging censorship within the agency.The scientists are demanding that Bhattacharya address the issue, asserting that researchers need the freedom to present findings without political oversight and to publish freely.
The letter follows allegations from former NIH nutrition scientist Kevin Hall, who claimed his research on ultra-processed foods was curtailed due to interference from superiors. The scientists are also requesting increased investment in nutrition research, proposing a budget increase to $4 billion.
Meanwhile, the Trump administration is urging pharmaceutical companies to voluntarily lower drug prices and allow direct sales to American consumers. While lower drug prices were a key campaign promise, industry executives are reportedly hesitant, citing a lack of specifics from the administration. The administration says it has provided companies with price targets based on the lowest prices offered in peer nations.
In other news, a report from the Urban Institute and the Robert Wood Johnson Foundation indicates that proposed work requirements for Medicaid expansion could cause one in three working or student enrollees to lose coverage. Researchers estimate that only a small fraction of those not working cite a lack of interest as the reason. Republicans argue that these work requirements are necessary to reduce federal spending, with projected savings of $280 billion over ten years.
Economist Genevieve P. Kanter of the University of Southern california suggests that Robert F. Kennedy Jr.’s approach to the vaccine advisory committee could be counterproductive. While removing members with industry ties might address conflicts of interest, Kanter argues that these members frequently enough bring valuable expertise to the table, as evidenced by their publication records.